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INTRODUCTION 
Life and diseases go together where there 
is life, diseases are bound to exist. 
Dependency and sustainability of man and 
animal life has been revolving around plants 
through their uses as food, clothing and 
shelter, but also plants have been used to 
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ABSTRACT 
Background and aims: Disease causing bacteria have always been considered a major 
cause of morbidity and mortality in humans. The appearance of resistant microorganisms 
paved the way to the occurrence of infections that are only treated by a limited number of 
antimicrobial agents. The present study was, the antimicrobial effects of Rosmarinus 
officinalis and Glycyrrhiza glabra extract against some pathogens. 
Methods: In this study, the antibacterial activity using 9 Gram-positive and Gram-negative 
bacterial strains includes: Streptococcus pyogenes ATCC® 19615, Streptococcus 
pneumoniae ATCC 49619, S. saprophyticus ATCC®15305, Hafnia alvei ATCC 51873, 
Acinetobacter baumannii ATCC 19606, Enterococcus faecalis ATCC 29212, Proteus 
mirabilis ATCC 35659, Serratia marcescens ATCC 274 and Staphylococcus aureus ATCC® 
25923 with micro dilution methods was studied. The MIC, MBC were studied also, 
resistance of these bacteria to standard antibiotics such as erythromycin, cefixime, 
ceftazidime, tetracycline, ampicillin and amikacin were compared. 
Results: In this study, the minimum inhibitory concentration (MIC) was used. The levels of 
MIC of R. officinalis were in ranges from 6.25 to 25 mg/ml. The highest MIC value was 
observed at 25 ppm against S. pyogenes, S. pneumoniae and P. mirabilis and the levels of 
MIC of G. glabra were in ranges from 6.25 to 12.5 ppm. The highest MIC value was 
observed at 12.5 ppm against S. pyogenes, S. pneumoniae, P. mirabilis and S. marcescens. 
Conclusion: In important human pathogens, drug resistance is increasing according to 
the results of this study, and may be proposed that this plant can be used as a drug. It can 
be a good way to replace herbs with chemical drugs. 
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control diseases. Therefore, the use of plants 
as medicines is an ancient and reliable 
practice.
1
 Glycyrrhiza glabra is a traditional 
herb which grows in various parts of the 
world. The term Glycyrrhiza has been derived 
from ancient Greek word glykos, meaning 
sweet and rhiza, meaning root.
2 
G. glabra, 
commonly called as Licorice, is one of the 
important traditional medicinal plants grows 
in the various part of the world and has been 
used for medicinal purposes for at least 4000 
years. The root of this plant has several useful 
pharmacological properties such as  
anti-inflammatory, antiviral, antimicrobial, 
and anticancer activities in addition to 
immunomodulatory, hepatoprotective and 
cardioprotective effects.
3
 Medicinally, it is 
used internally for Addison’s disease, Asthma, 
Bronchitis, Peptic ulcer, Arthritis, Allergic 
complaints and steroid therapy. Externally, 
liquorices are used for Eczema, Herpes and 
Shingles. These activities are reported due to 
two kinds of main constituents, the saponins 
and flavonoids present in G. glabra. Topical 
applications of such compounds, with free-
radical-scavenging properties, have shown to 
improve
5 
significantly wound healing and 
protect tissues from oxidative damage.
4
 
Rosemary (Rosmarinus officinalis L.) is 
an aromatic plant and thus a flavouring agent, 
widely used in foods. Its extracts have been 
introduced as preservatives in the food 
industry). Rosemary extract formulations are 
the only ones commercially available for use 
as antioxidants in the European Union and the 
United States, and they are marketed in an  
oil-soluble form, as a dry powder, and in 
water-dispersible or water-miscible 
formulations.
6
 Rosemary is used for 
flavouring meat and poultry dishes. Thyme 
adds a pungent taste to meat and vegetables, 
and is the main ingredient for garnishing 
soups and stews. Basil is a classic complement 
to tomatoes, and is used to flavor salads, 
sauces and vegetables. Sage is widely used for 
flavouring meat dishes, soups, sausages and 
canned food.
7
 These compounds may protect 
cholesterol from oxidation, inhibit 
cyclooxygenase and lipoxygenase enzymes, 
inhibit lipid peroxidation, or have antiviral or 
anti-tumour activity. Essential oils of culinary 
herbs can inhibit mevalonate synthesis and 
thereby suppress cholesterol synthesis and 
tumour growth. 
The present study was, the antimicrobial 
effects of R. officinalis and G. glabra extracts 
against some pathogens. 
 
METHODS 
Bacterial strains were obtained from the 
microbial culture collection of Kerman 
University of Medical Sciences (KUMS). 
Evaluating the antibacterial activity of the 
plant extracts were investigated using a strain 
of bacteria Streptococcus pyogenes ATCC® 
19615™, Streptococcus pneumoniae ATCC 
49619, S. saprophyticus ATCC®15305, 
Hafnia alvei ATCC 51873, Acinetobacter. 
baumannii ATCC 19606, Enterococcus 
faecalis ATCC 29212, Proteus mirabilis 
ATCC 35659, Serratia marcescens ATCC 
274. The typed cultures of bacteria were  
sub-cultured on Nutrient agar (Oxoid, 
England) and stored at 4oC until required for 
study. 
The susceptibility of all antibiotics was 
carried out using disc diffusion method on 
Muller-Hinton agar as recommended by 
CLSI. The procedure followed is briefly 
described here. Streptococcus pyogenes 
ATCC® 19615™, Streptococcus pneumoniae 
ATCC 49619, S. saprophyticus 
ATCC®15305, Hafnia alvei ATCC 51873, 
Acinetobacter. baumannii ATCC 19606, 
Enterococcus faecalis ATCC 29212, Proteus 
mirabilis ATCC 35659, Serratia marcescens 
ATCC 274 plates were grown overnight on 
blood agar, Nutrient agar and colony 
suspension was prepared using the sterile 
saline water equivalent to a 0.5 McFarland 
standard. Suspension (100 μl) was spread over 
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the medium plate and antibiotic disc was 
transferred aseptically to the surface of the 
inoculated medium plate. Isolated plates were 
tested with different antibiotics and their 
concentration shown in parenthesis viz. 
ceftazidim, erythromycin, ceftazidime, 
ampicillin, amikacin and tetracycline (Padtan 
Teb Co, Iran). 
The leaf of R. officinalis and G. glabra 
was collected in the region of Iran  
(Zabol- southeastern, Iran) and dried at room 
temperature. Samples were crushed and 
transferred into glass container and preserved 
until extraction procedure was performed in 
the laboratory. 
For preparing of extracts, plants were 
properly dried and pulverized into a coarse 
powder. Each of 40 g grinded powders was 
soaked in 50 ml ethanol 95%, separately for 
20 h (shaking occasionally with a shaker). 
After one day of dissolving process, materials 
were filtered (Whatman no. 1 filter paper). 
Then, the filtrates were evaporated using a 
rotary evaporator. At last, 0.97 g of dried 
extracts were obtained and then stored at 40C 
in air tight screw-cap tube. 
The broth microdilution method was used 
to determine MIC and MBC. All tests were 
performed in Mueller Hinton broth (Merck, 
Germany) supplemented with Tween 80 
(Merck, Germany) at a final concentration of 
0.5% (v/ v). Briefly, serial doubling dilutions 
of the extract were prepared in a 96-well 
microtiter plate ranged from 12.5 mg/ml to 
400 mg/ml. To each well, 10 μl of indicator 
solution and 10 μl of Mueller Hinton Broth 
were added. Finally, 10 μl of bacterial 
suspension (10
6
 CFU/ml) was added to each 
well to achieve a concentration of 104 
CFU/ml. The plates were wrapped loosely 
with cling film to ensure that the bacteria did 
not get dehydrated. The plates were prepared 
in triplicates, and then they were placed in an 
incubator at 37°C for 18-24 hours. The color 
change was then assessed visually. The lowest 
concentration at which the color change 
occurred was taken as the MIC value. The 
average of 3 values was calculated providing 
the MIC values for the tested extract. The 
MIC is defined as the lowest concentration of 
the extract at which the microorganism does 
not demonstrate the visible growth. The 
microorganism growth was indicated by 
turbidity. The MBC was defined as the lowest 
concentration of the extracts at which the 
incubated microorganism was completely 
killed. 
 
RESULTS 
In this study, the minimum inhibitory 
concentration (MIC) was used. The levels of 
MIC of R. officinalis were in ranges from  
6.25 to 25 ppm. The highest MIC value was 
observed at 25 ppm against S. pyogenes,  
S. pneumoniae and P. mirabilis (Table 1). 
 
Table1: Antimicrobial susceptibility, MIC and MBC extract plant for Standard bacteria 
Antibiotic patent MIC/MBC G. glabra MIC/MBC R. officinalis Bacterial 
- 12.5/25 25/50 Streptococcus pyogenes 
E,CE,CF, AM 12.5/25 25/50 Streptococcus pneumoniae 
E,TE, AM 6.25/12.5 12.5/25 Hafinia alvei 
E,CF,TE, AM 6.25/12.5 12.5/25 S. saprophyticus 
CE,TE 6.25/12.5 6.25/12.5 Acintobacter baumannii 
E,CE, AM 6.25/12.5 12.5/25 Enterococcus faecalis 
E,TE, AM 12.5/25 25/50 Proteus mirabilis 
CE 12.5/25 12.5/25 Serratia marcescens 
E,CE, AM 12.5/25 25/50 Staphylococcus aureus 
E: Erythromycin, CE: Cefixime, CF: Ceftazidime, TE: Tetracycline, AM:Ampicillin, AN:Amikacin. 
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The highest MBC for R. officinalis 
leave was 50 ppm, while the lowest MBC 
was 12.5 ppm and the levels of MIC of  
G. glabra were in ranges from 6.25 to  
12.5 ppm. The highest MIC value was 
observed at 12.5 ppm against S. pyogenes,  
S. pneumoniae, P. mirabilis and  
S. marcescens (Table 1). The highest MBC 
for G. glabra leave was 12.5 ppm, while the 
lowest MBC was 25 ppm. 
 
DISCUSSION 
The study of Sedighinia, evaluated the 
antibacterial activity of G. glabra against 
oral pathogens by diffusion methods and 
determined the minimum inhibitory 
concentration (MIC) by both broth and Agar 
dilution methods and minimum bactericidal 
concentration (MBC) by broth dilution 
methods and the results show that G. glabra 
extract showed good antibacterial activity 
against six bacteria. No strain in this study 
showed resistance against this extract.
8
 
The ethanolic extract of G. glabra had 
promising MIC value against all oral bacteria 
especially S. mutans, A. viscosus, and  
E. faecalis. Although in some studies, it has 
been reported that G. glabra extract has 
antibacterial activity against several bacteria 
such as S. aureus, E. faecalis, and E. coli, but 
there are a few studies about oral pathogens 
such as A. viscosus and S. sanguis.
9
 
The study of Syed was to test the 
antimicrobial activities of crude chloroform, 
hexane, ethyl acetate and ethanol extracts  
of the leaves G. glabra (GG) and  
Fagonia arabica (FA) against bacteria 
(Escherichia coli, Staphylococcus epidermidis, 
Staphylococcus aureus and Bacillus subtilis). 
Antimicrobial properties of G. glabra and  
F. arabica were tested using Agar well 
diffusion method. Streptomycine was used 
as standard drug with significant activity 
values, that is, 23 mm against E. coli,  
36 mm against S. epidermidis, and 34 mm 
against S. aureus and 26 mm against  
B. subtilis. Analysis of data showed that the 
crude extract of G. glabra and F. arabica in 
dichloromethane exhibited superior activity 
against E. coli and S. epidermidis.
10
 
In the study of Nirmala and Selvaraj, 
the anti-bacterial activities of the methanol, 
ethyl acetate, acetone and chloroform 
extracts of G. glabra plant roots were tested 
against six bacterial species viz., Bacillus 
coagulans, Enterococcus faecalis, 
Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus and Salmonella 
typhimurium by the agar disc diffusion 
method. The results indicated that the 
extract of G. glabra showed various 
antibacterial activities (9-14mm/20µl 
inhibition zone) against the bacterial 
organisms tested. The methanol, ethyl 
acetate, acetone and chloroform extracts did 
not inhibit Enterococcus faecalis, 
Pseudomonas aeruginosa and Staphylococcus 
aureus but showed the inhibition effect against 
B. coagulans, E. coli and S. typhimurium.
9
 
In the study of Patil, The antimicrobical 
potential of G. glabra Linn. against certain 
microorganisms was studied using agar 
diffusion method. The aqueous and 
ethanolic extract of G. glabra roots 
significantly inhibited the growth of 
microorganisms as compared to standard 
bactericide and fungicide drugs. Diethyl 
ether fraction exhibited prominent fungicidal 
activity against Candida albicans.
11
 
The study of Golshani and Dawoodi 
showed that Rosmarinus officinalis was used 
to evaluate its antimicrobial effects. The result 
show that the most efficacy of than extract of 
rosemary leaves was at concentration of  
400 mg/ml against Pseudomonas aeruginosa 
and Escherichia coli. minimum inhibitory 
concentration of the extract on the growth of 
these bacteria showed changes from  
6.25 mg/ml to 100 mg/ml. Also MBC of 
extract showed range from 12.5 to  
200 mg/ml respectively.
12
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The study of Tavassoli and Emam 
Djomeh revealed antioxidant activity and 
antimicrobial activity of rosemary leaves 
extract. Dry rosemary leaf powder was 
subjected to Soxhlet extraction with pure 
methanol. The antimicrobial activity of 
rosemary leaves extract against Leuconostoc 
mesenteroides, Lactobacillus delbruekii, 
Saccharomyces cerevisia and Candida 
krusei (Issatchenikia orientalis) were 
determined by minimum inhibitory 
concentration (MIC).
13
 
The effect of rosemary extracts was 
examined in the study of Klancnik against 
the foodborne pathogenic bacteria S. aureus, 
B. cereus, C. jejuni, and Salmonella Infantis. 
Gram positive strains were much more 
sensitive to rosemary extracts. For example, 
by the agar dilution method, the MIC for  
S. aureus and B. cereus was 0.078 to  
5.0 mg/ml, whereas for Salmonella, it was 
5.0 to 10.0 mg/ml.
14
 
The study of Jarrar determines the 
antimicrobial activity of rosemary 
(Rosmarinus officinalis L.) and investigates 
the synergistic effects of this extract 
combined with ceforuxime against 
methicillin resistant Staphylococcus aureus 
(MRSA).
15
 
The study of Derwich evaluates the 
antibacterial activities of these aromatic 
extracts such as Rosmary. There in vitro 
antibacterial activity was determined by disk 
diffusion testing and minimum inhibitory 
concentration (MIC). Escherichia coli, 
Pseudomonas aeruginosa, Staphylococcus 
aureus, Kellebsiella pneuomonae, Salmonella 
typhi, Staphylococcus intermedius, Bacillus 
subtilis, Streptococcus mutans, Micrococcus 
luteus, and Proteus mirabilis were used as 
test bacterial strains. The analyses for leaves 
resulted in the identification of forty seven 
compounds, representing 65.61% of the total 
oil and the yields were 0.54%. The major 
component was α‐pinene (18.25%); other 
predominant components were camphor 
(6.02%), 1.8‐cineole (5.25%), camphene 
(5.02%), β‐pinene (4.58%), bornylacetate 
(4.35%), limonene (3.56%), borneol 
(3.10%), α‐terpineol (2.89%) and cymene 
(2.02%). The bacterial strains tested were 
inhibited at minimum inhibitory 
concentration (MIC) values in the range of  
4 at 48.2 µg/mL.
16
 
 
CONCLUSION 
The extract were found to have 
significant antibacterial activity and 
therefore can be used as a natural 
antimicrobial agent for the treatment of 
several infectious diseases caused by these 
germs, which have developed resistance to 
antibiotics. 
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